Cost-effectiveness of cetuximab in metastatic colorectal cancer ((send by free-web-host.me user))
From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.
Read more ...
Posted in: on Wednesday, August 19, 2009 at at 1:26 AM
